EPI-589 is under investigation in clinical trial NCT02460679 (Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS)).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.